Fortis Healthcare Limited — Important, 14-07-2025: General Updates

Fortis Healthcare delivered strong full-year results with revenue rising to ₹ 7,783 Cr and EBITDA at ₹ 1,655 Cr, showcasing improved efficiency. The Board proposes a ₹1/share dividend. Strategically, Fortis increased its Agilus Diagnostics stake to 89.20% through a ₹ 1,550 Cr NCD issuance, acquiring the 'Fortis' brand for ₹ 200 Cr, and buying Shrimann Superspecialty Hospital for ₹ 462 Cr, significantly expanding bed capacity. Divestment of the Richmond Road facility streamlines operations, while tech upgrades enhance patient care.